Gitali Devi

Gitali is a senior scientist, in RNA/oligonucleotide chemistry at Verve Therapeutics. Gitali completed her Ph.D. in chemistry at National Chemical Laboratory, India, where she was introduced to the nucleic acid therapeutics area. She pursued her postdoctoral research at Nanyang Technological University, Singapore, with a particular focus on synthesizing new drug modalities including PNA, G-quadruplex, and molecular conjugates to achieve better antisense and drug delivery properties. Prior to Verve, she worked as a research specialist at UMass Chan Medical School. There, her work focused on prime editing guides and single guide RNA modifications and on the development of new chemical methods to make various antisense oligonucleotide architectures, which could potentially improve cellular uptake and induce gene regulation.